Pertussis (whooping cough) is well known to be underreported, particularly among adults, who can act as an infectious reservoir, potentially putting susceptible newborns at risk of serious illness. The purpose of this study was to estimate the seroprevalence of pertussis in adults in Hungary.
This epidemiological, cross-sectional study was conducted in adults in five general practitioners’ practices in Hungary. Serum anti-pertussis toxin immunoglobulin G (anti-PT IgG) antibody levels were analyzed using enzyme-linked immunosorbent assay. Sera were classified following manufacturer’s instructions as: strongly indicative of current/recent infection (≥1.5 optical density [OD] units); indicative of current/recent infection (≥1.0 OD units); seropositive (>0.3 OD units); or seronegative (≤0.3 OD units). Logistic regression was performed to describe the associations between seroprevalence and various characteristics.
Between 24th April 2014 and 24th April 2015, 1999 adults (60.6% female; mean age 47.4 ± 17.7 years) were included in the analysis. A total of 14.8% were seropositive for anti-PT IgG, 1.1% had a level indicative of current/recent infection, and 0.1% had a level strongly indicative of current/recent infection. Logistic regression showed significant relationships between increased rates of seropositivity and: age ≥60 years (odds ratio [OR], 1.97; 95% confidence interval [CI], 1.39–2.80; p = .0002) or 18–29 years (OR, 1.67; 95% CI, 1.13–2.46; p = .0094) vs. 45–59 years; former smoker (OR, 1.46; 95% CI, 1.08–1.97; p = .014) or current smoker (OR, 1.38; 95% CI, 1.01–1.89; p = .045) vs. never smoker; and male (OR, 1.30; 95% CI, 1.01–1.68; p = .041) vs. female. Also, between increased rates of probable current/recent infection and current smoker (OR, 7.50; 95% CI, 2.32–24.31; p = .0008) or former smoker (OR, 4.07; 95% CI, 1.21–13.64; p = .023) vs. never smoker.
Approximately 85% of the adults studied were seronegative and therefore susceptible to pertussis infection. Approximately 1% had anti-PT IgG levels indicative of current/recent pertussis infection, which could potentially be transmitted to susceptible young infants. Vaccination of adults is a key way to indirectly protect infants.
Clinical Trials.gov NCT02014519. Prospectively registered 12 December 2013.
Pertussis. European Centre for Disease Prevention and Control (ECDC). 2016. http://ecdc.europa.eu/en/healthtopics/pertussis/Pages/index.aspx. Accessed 22 Jun 2016.
Joo I. Epidemiology of pertussis in Hungary. Dev Biol Stand. 1991;73:357–9. PubMed
Vaccine Schedule. Immunisation schedules by target disease [pertussis] in [Hungary]. European Centre for Disease Prevention and Control (ECDC). 2016. http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx. Accessed 20 Jun 2016.
Országos Epidemiológiai Központ [National Epidemiology Center]. Védőoltások teljesítése, 2015 [Vaccinations performance of 2015]. Epinfo. 2016;23:369–81. http://www.oek.hu/oekfile.pl?fid=6840. Accessed 8 Sep 2016.
Esposito S, Principi N, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Vaccine Study Group (EVASG). Immunization against pertussis in adolescents and adults. Clin Microbiol Infect. 2016;22(Suppl 5):S89-S95.
World Health Organization (WHO). Pertussis vaccines: WHO position paper, August 2015 – Recommendations. Vaccine. 2016;34:1423–5. CrossRef
Recommended immunisations for pertussis [All EU countries]. European Centre for Disease Prevention and Control (ECDC). 2016. http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx. Accessed 19 Jul 2016.
European Centre for Disease Prevention and Control (ECDC). Expert consultation on pertussis 2012. http://ecdc.europa.eu/en/publications/Publications/pertussis-meeting-2012.pdf. Accessed 22 Jun 2016.
Surveillance Atlas of Infectious Diseases. European Centre for Disease Prevention and Control (ECDC). 2016. http://atlas.ecdc.europa.eu/public/index.aspx?. Accessed 22 June 2016.
Országos Epidemiológiai Központ [National Epidemiology Center]. Fertőző betegségek adatai [data on infectious diseases]. Epinfo. 2016;22:640–50. http://www.oek.hu/oekfile.pl?fid=6451. Accessed 5 Sept 2016.
Population Pyramids of the World from 1950 to 2100. Hungary 2015. http://populationpyramid.net/hungary/2015/. Accessed 8 Sep 2016.
Barkoff AM, Gröndahl-Yli-Hannuksela K, He Q. Seroprevalence studies of pertussis: what have we learned from different immunized populations. Pathog Dis. 2015;73:ftv050.
Cutts FT, Hanson M. Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries. Tropical Med Int Health. 2016;21:1086–98. CrossRef
Euro Diagnostica. Instruction: PERTUSSCAN PT IgG: ELISA for detection of IgG against Bordatella pertussis toxin (PT) in serum. Malmö: Euro Diagnostica; 2013. p. 120. Document No.: E-23-0207-02
González-Escalada A, García-García L, Viguera-Ester P, Marín-García P, García J, Gil-de-Miguel A, et al. Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain. Hum Vaccin Immunother. 2013;9:1918–25. CrossRefPubMedPubMedCentral
Palazzo R, Carollo M, Fedele G, Rizzo C, Rota MC, Giammanco A, et al. Evidence of increased circulation of Bordetella pertussis in the Italian adult population from seroprevalence data (2012–2013). J Med Microbiol. 2016:[Epub ahead of print].
Recommended Adult Immunization Schedule for Adults Aged 19 Years or Older, by Vaccine and Age Group. United States, 2016. Centers for Disease Control and Prevention (CDC). 2016. http://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html. Accessed 20 Jul 2016.
Caboré RN, Piérard D, Huygen K. A Belgian Serosurveillance/Seroprevalence Study of Diphtheria, Tetanus and Pertussis Using a Luminex xMAP Technology-Based Pentaplex. Vaccines (Basel). 2016;4:E16.
Chen Z, Zhang J, Cao L, Zhang N, Zhu J, Ping G, et al. Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years. J Infect. 2016;73:38–44.
de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect. 2006;53:106–13.
Carcione D, Regan AK, Tracey L, Mak DB, Gibbs R, Dowse GK, et al. The impact of parental postpartum pertussis vaccination on infection in infants: a population-based study of cocooning in Western Australia. Vaccine. 2015;33:5654–61.
- Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II